Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical landscape of TP73 structural variants in ATL patients.
Hiramatsu H, Yokomori R, Shengyi L, Tanaka N, Mori S, Kiyotani K, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Sanda T, Ishida T. Hiramatsu H, et al. Among authors: kiyotani k. Leukemia. 2023 Dec;37(12):2502-2506. doi: 10.1038/s41375-023-02059-9. Epub 2023 Oct 20. Leukemia. 2023. PMID: 37864123 Free PMC article. No abstract available.
Immunogenomic landscape of gynecologic carcinosarcoma.
Gotoh O, Kiyotani K, Chiba T, Sugiyama Y, Takazawa Y, Nemoto K, Kato K, Tanaka N, Nomura H, Hasegawa K, Fujiwara K, Takamatsu S, Matsumura N, Noda T, Mori S. Gotoh O, et al. Among authors: kiyotani k. Gynecol Oncol. 2021 Feb;160(2):547-556. doi: 10.1016/j.ygyno.2020.11.030. Epub 2020 Dec 6. Gynecol Oncol. 2021. PMID: 33298310
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Tanaka N, Mori S, Kiyotani K, Ota Y, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Ishida T. Tanaka N, et al. Among authors: kiyotani k. Haematologica. 2022 Oct 1;107(10):2418-2431. doi: 10.3324/haematol.2021.280352. Haematologica. 2022. PMID: 35417939 Free PMC article.
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
Yap KL, Furtado LV, Kiyotani K, Curran E, Stock W, McNeer JL, Kadri S, Segal JP, Nakamura Y, Le Beau MM, Gurbuxani S, Raca G. Yap KL, et al. Among authors: kiyotani k. Leuk Lymphoma. 2017 Apr;58(4):950-958. doi: 10.1080/10428194.2016.1219902. Epub 2016 Nov 17. Leuk Lymphoma. 2017. PMID: 27855558 Free PMC article.
Druggable gene alterations in Japanese patients with rare malignancy.
Ohmoto A, Hayashi N, Fukada I, Yamazaki M, Yunokawa M, Kasuga A, Shinozaki E, Ueki A, Tonooka A, Takeuchi K, Mori S, Kiyotani K, Takahashi S. Ohmoto A, et al. Among authors: kiyotani k. Neoplasia. 2022 Nov;33:100834. doi: 10.1016/j.neo.2022.100834. Epub 2022 Sep 8. Neoplasia. 2022. PMID: 36088851 Free PMC article.
Personalized immunotherapy in cancer precision medicine.
Kiyotani K, Toyoshima Y, Nakamura Y. Kiyotani K, et al. Cancer Biol Med. 2021 Aug 9;18(4):955-65. doi: 10.20892/j.issn.2095-3941.2021.0032. Online ahead of print. Cancer Biol Med. 2021. PMID: 34369137 Free PMC article. Review.
Immunogenomics in personalized cancer treatments.
Kiyotani K, Toyoshima Y, Nakamura Y. Kiyotani K, et al. J Hum Genet. 2021 Sep;66(9):901-907. doi: 10.1038/s10038-021-00950-w. Epub 2021 Jun 30. J Hum Genet. 2021. PMID: 34193979 Review.
185 results